Human pericardial proteoglycan 4 (lubricin)

Implications for postcardiotomy intrathoracic adhesion formation

Daniel S.J. Park, Suresh C. Regmi, Daniyil A. Svystonyuk, Guoqi Teng, Darrell Belke, Jeannine Turnbull, David G. Guzzardi, Sean Kang, Mary Cowman, Tannin A. Schmidt, Paul W.M. Fedak

Research output: Contribution to journalArticle

Abstract

Objective: Intrapericardial fibrous adhesions increase the risk of sternal reentry. Proteoglycan 4/lubricin (PRG4) is a mucin-like glycoprotein that lubricates tissue compartments and prevents inflammation. We characterized PRG4 expression in human pericardium and examined its effects in vitro on human cardiac myofibroblast fibrotic activity and in vivo as a measure of its therapeutic potential to prevent adhesions. Methods: Full-length PRG4 expression was determined using Western blot analysis and amplified luminescent proximity homogeneous assay in human pericardial tissues obtained at cardiotomy. The in vitro effects of PRG4 were investigated on human cardiac myofibroblasts for cell adhesion, collagen gel contraction, and cell-mediated extracellular matrix remodeling. The influence of PRG4 on pericardial homeostasis was determined in a chronic porcine animal model. Results: PRG4 is expressed in human pericardial fluid and colocalized with pericardial mesothelial cells. Recombinant human PRG4 prevented human cardiac myofibroblast attachment and reduced myofibroblast activity assessed using collagen gel contraction assay (64.6% ± 8.1% vs 47.1% ± 6.8%; P = .02). Using a microgel assay, human cardiac myofibroblast mediated collagen fiber remodeling was attenuated by PRG4 (1.17 ± 0.03 vs 0.90 ± 0.05; P = .002). In vivo, removal of pericardial fluid alone induced severe intrapericardial adhesion formation, tissue thickening, and inflammatory fluid collections. Restoration of intrapericardial PRG4 was protective against fibrous adhesions and preserved the pericardial space. Conclusions: For the first time, we show that PRG4 is expressed in human pericardial fluid and regulates local fibrotic myofibroblast activity. Loss of PRG4-enriched pericardial fluid after cardiotomy might induce adhesion formation. Therapeutic restoration of intrapericardial PRG4 might prevent fibrous/inflammatory adhesions and reduce the risk of sternal reentry.

Original languageEnglish (US)
JournalJournal of Thoracic and Cardiovascular Surgery
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Proteoglycans
Myofibroblasts
Collagen
Pericardium
lubricin
human PRG4 protein
Gels
Tissue Adhesions
Mucins
Cell Adhesion
Extracellular Matrix
Glycoproteins
Homeostasis
Swine
Animal Models
Western Blotting
Inflammation

Keywords

  • ibroblasts
  • proteoglycan 4
  • surgical adhesions

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Human pericardial proteoglycan 4 (lubricin) : Implications for postcardiotomy intrathoracic adhesion formation. / Park, Daniel S.J.; Regmi, Suresh C.; Svystonyuk, Daniyil A.; Teng, Guoqi; Belke, Darrell; Turnbull, Jeannine; Guzzardi, David G.; Kang, Sean; Cowman, Mary; Schmidt, Tannin A.; Fedak, Paul W.M.

In: Journal of Thoracic and Cardiovascular Surgery, 01.01.2018.

Research output: Contribution to journalArticle

Park, Daniel S.J. ; Regmi, Suresh C. ; Svystonyuk, Daniyil A. ; Teng, Guoqi ; Belke, Darrell ; Turnbull, Jeannine ; Guzzardi, David G. ; Kang, Sean ; Cowman, Mary ; Schmidt, Tannin A. ; Fedak, Paul W.M. / Human pericardial proteoglycan 4 (lubricin) : Implications for postcardiotomy intrathoracic adhesion formation. In: Journal of Thoracic and Cardiovascular Surgery. 2018.
@article{42d24afb48b34d0cabc5561e0fea4a8d,
title = "Human pericardial proteoglycan 4 (lubricin): Implications for postcardiotomy intrathoracic adhesion formation",
abstract = "Objective: Intrapericardial fibrous adhesions increase the risk of sternal reentry. Proteoglycan 4/lubricin (PRG4) is a mucin-like glycoprotein that lubricates tissue compartments and prevents inflammation. We characterized PRG4 expression in human pericardium and examined its effects in vitro on human cardiac myofibroblast fibrotic activity and in vivo as a measure of its therapeutic potential to prevent adhesions. Methods: Full-length PRG4 expression was determined using Western blot analysis and amplified luminescent proximity homogeneous assay in human pericardial tissues obtained at cardiotomy. The in vitro effects of PRG4 were investigated on human cardiac myofibroblasts for cell adhesion, collagen gel contraction, and cell-mediated extracellular matrix remodeling. The influence of PRG4 on pericardial homeostasis was determined in a chronic porcine animal model. Results: PRG4 is expressed in human pericardial fluid and colocalized with pericardial mesothelial cells. Recombinant human PRG4 prevented human cardiac myofibroblast attachment and reduced myofibroblast activity assessed using collagen gel contraction assay (64.6{\%} ± 8.1{\%} vs 47.1{\%} ± 6.8{\%}; P = .02). Using a microgel assay, human cardiac myofibroblast mediated collagen fiber remodeling was attenuated by PRG4 (1.17 ± 0.03 vs 0.90 ± 0.05; P = .002). In vivo, removal of pericardial fluid alone induced severe intrapericardial adhesion formation, tissue thickening, and inflammatory fluid collections. Restoration of intrapericardial PRG4 was protective against fibrous adhesions and preserved the pericardial space. Conclusions: For the first time, we show that PRG4 is expressed in human pericardial fluid and regulates local fibrotic myofibroblast activity. Loss of PRG4-enriched pericardial fluid after cardiotomy might induce adhesion formation. Therapeutic restoration of intrapericardial PRG4 might prevent fibrous/inflammatory adhesions and reduce the risk of sternal reentry.",
keywords = "ibroblasts, proteoglycan 4, surgical adhesions",
author = "Park, {Daniel S.J.} and Regmi, {Suresh C.} and Svystonyuk, {Daniyil A.} and Guoqi Teng and Darrell Belke and Jeannine Turnbull and Guzzardi, {David G.} and Sean Kang and Mary Cowman and Schmidt, {Tannin A.} and Fedak, {Paul W.M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jtcvs.2018.03.170",
language = "English (US)",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Human pericardial proteoglycan 4 (lubricin)

T2 - Implications for postcardiotomy intrathoracic adhesion formation

AU - Park, Daniel S.J.

AU - Regmi, Suresh C.

AU - Svystonyuk, Daniyil A.

AU - Teng, Guoqi

AU - Belke, Darrell

AU - Turnbull, Jeannine

AU - Guzzardi, David G.

AU - Kang, Sean

AU - Cowman, Mary

AU - Schmidt, Tannin A.

AU - Fedak, Paul W.M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Intrapericardial fibrous adhesions increase the risk of sternal reentry. Proteoglycan 4/lubricin (PRG4) is a mucin-like glycoprotein that lubricates tissue compartments and prevents inflammation. We characterized PRG4 expression in human pericardium and examined its effects in vitro on human cardiac myofibroblast fibrotic activity and in vivo as a measure of its therapeutic potential to prevent adhesions. Methods: Full-length PRG4 expression was determined using Western blot analysis and amplified luminescent proximity homogeneous assay in human pericardial tissues obtained at cardiotomy. The in vitro effects of PRG4 were investigated on human cardiac myofibroblasts for cell adhesion, collagen gel contraction, and cell-mediated extracellular matrix remodeling. The influence of PRG4 on pericardial homeostasis was determined in a chronic porcine animal model. Results: PRG4 is expressed in human pericardial fluid and colocalized with pericardial mesothelial cells. Recombinant human PRG4 prevented human cardiac myofibroblast attachment and reduced myofibroblast activity assessed using collagen gel contraction assay (64.6% ± 8.1% vs 47.1% ± 6.8%; P = .02). Using a microgel assay, human cardiac myofibroblast mediated collagen fiber remodeling was attenuated by PRG4 (1.17 ± 0.03 vs 0.90 ± 0.05; P = .002). In vivo, removal of pericardial fluid alone induced severe intrapericardial adhesion formation, tissue thickening, and inflammatory fluid collections. Restoration of intrapericardial PRG4 was protective against fibrous adhesions and preserved the pericardial space. Conclusions: For the first time, we show that PRG4 is expressed in human pericardial fluid and regulates local fibrotic myofibroblast activity. Loss of PRG4-enriched pericardial fluid after cardiotomy might induce adhesion formation. Therapeutic restoration of intrapericardial PRG4 might prevent fibrous/inflammatory adhesions and reduce the risk of sternal reentry.

AB - Objective: Intrapericardial fibrous adhesions increase the risk of sternal reentry. Proteoglycan 4/lubricin (PRG4) is a mucin-like glycoprotein that lubricates tissue compartments and prevents inflammation. We characterized PRG4 expression in human pericardium and examined its effects in vitro on human cardiac myofibroblast fibrotic activity and in vivo as a measure of its therapeutic potential to prevent adhesions. Methods: Full-length PRG4 expression was determined using Western blot analysis and amplified luminescent proximity homogeneous assay in human pericardial tissues obtained at cardiotomy. The in vitro effects of PRG4 were investigated on human cardiac myofibroblasts for cell adhesion, collagen gel contraction, and cell-mediated extracellular matrix remodeling. The influence of PRG4 on pericardial homeostasis was determined in a chronic porcine animal model. Results: PRG4 is expressed in human pericardial fluid and colocalized with pericardial mesothelial cells. Recombinant human PRG4 prevented human cardiac myofibroblast attachment and reduced myofibroblast activity assessed using collagen gel contraction assay (64.6% ± 8.1% vs 47.1% ± 6.8%; P = .02). Using a microgel assay, human cardiac myofibroblast mediated collagen fiber remodeling was attenuated by PRG4 (1.17 ± 0.03 vs 0.90 ± 0.05; P = .002). In vivo, removal of pericardial fluid alone induced severe intrapericardial adhesion formation, tissue thickening, and inflammatory fluid collections. Restoration of intrapericardial PRG4 was protective against fibrous adhesions and preserved the pericardial space. Conclusions: For the first time, we show that PRG4 is expressed in human pericardial fluid and regulates local fibrotic myofibroblast activity. Loss of PRG4-enriched pericardial fluid after cardiotomy might induce adhesion formation. Therapeutic restoration of intrapericardial PRG4 might prevent fibrous/inflammatory adhesions and reduce the risk of sternal reentry.

KW - ibroblasts

KW - proteoglycan 4

KW - surgical adhesions

UR - http://www.scopus.com/inward/record.url?scp=85047652176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047652176&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2018.03.170

DO - 10.1016/j.jtcvs.2018.03.170

M3 - Article

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

ER -